Benzinga··Kaustubh BagalkoteSciSparc Surges 157% on Quantum Clinical Trial Deal Regulatory Nod
SciSparc surges 157% after subsidiary NeuroThera receives regulatory approval to acquire 54% of Israeli quantum clinical analytics firm CliniQuantum for $9.5M.
SPRCacquisitionregulatory approval